JPMorgan Chase & Co’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Sell |
|
|||||
|
2025
Q1 | $18.2M | Sell |
|
|||||
|
2024
Q4 | $23.8M | Buy |
|
|||||
|
2024
Q3 | $23.3M | Sell |
|
|||||
|
2024
Q2 | $30.1M | Sell |
|
|||||
|
2024
Q1 | $31.2M | Sell |
|
|||||
|
2023
Q4 | $26.5M | Sell |
|
|||||
|
2023
Q3 | $25.7M | Sell |
|
|||||
|
2023
Q2 | $28.2M | Buy |
|
|||||
|
2023
Q1 | $19.1M | Buy |
|
|||||
|
2022
Q4 | $18.8M | Sell |
|
|||||
|
2022
Q3 | $16.9M | Sell |
|
|||||
|
2022
Q2 | $17M | Buy |
|
|||||
|
2022
Q1 | $17.2M | Buy |
|
|||||
|
2021
Q4 | $14M | Sell |
|
|||||
|
2021
Q3 | $11.7M | Sell |
|
|||||
|
2021
Q2 | $27.9M | Buy |
|
|||||
|
2021
Q1 | $29.6M | Buy |
|
|||||
|
2020
Q4 | $14.4M | Buy |
|
|||||
|
2020
Q3 | $3.62M | Buy |
|
|||||
|
2020
Q2 | $2.8M | Buy |
|
|||||
|
2020
Q1 | $2.02M | Buy |
|
|||||
|
2019
Q4 | $1.09M | Buy |
|
|||||
|
2019
Q3 | $119K | Sell |
|
|||||
|
2019
Q2 | $741K | Buy |
|
|||||
|
2019
Q1 | $218K | Buy |
|
|||||
|
2018
Q4 | $25K | Sell |
|
|||||
|
2018
Q3 | $635K | Buy |
|
|||||
|
2018
Q2 | $318K | Buy |
|